Ronald Blue & Co’s DexCom DXCM Stock Holding History

Ronald Blue & Co’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,412	Closed	-$224K	–	222
2015 Q3	$224K	Buy	+10,412	New	+$232K	0.01%	262

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ronald Blue & Co's DXCM Position: Q4 2015 in Review

Ronald Blue & Co sold out of DexCom (DXCM) in Q4 2015, closing a stake of 10,412 shares — an estimated $224K sold.

Ronald Blue & Co first reported a position in DXCM in Q3 2015 and held it in 1 quarter. The position peaked at $224K in Q3 2015. 287 funds tracked by Wall St. Rank hold DXCM as of Q4 2015.

Ronald Blue & Co reported no remaining DexCom position as of Q4 2015 after selling out during the quarter.
Ronald Blue & Co sold 10,412 DexCom shares in Q4 2015, an estimated $224K.
Ronald Blue & Co first reported a position in DexCom in Q3 2015 and held it in 1 quarter.
Ronald Blue & Co's DexCom position peaked at $224K in Q3 2015.
287 funds tracked by Wall St. Rank held DexCom as of Q4 2015.

Based on Ronald Blue & Co's 13F filing for Q4 2015, filed 11 Feb 2016.